{
    "title": "Drugmaker backpedals on specialty status for COVID-19 drug",
    "url": "https://www.dailymail.co.uk/wires/ap/article-8153165/Drugmaker-backpedals-specialty-status-COVID-19-drug.html",
    "date": "2020-03-25",
    "keywords": [
        "drug",
        "gilead",
        "status",
        "company",
        "coronavirus",
        "designation",
        "disease",
        "covid19",
        "health",
        "file",
        "wednesday",
        "treatment",
        "fda",
        "ap",
        "program",
        "science",
        "department",
        "washington",
        "criticism",
        "maker",
        "competition",
        "marketing",
        "food",
        "administration",
        "companys",
        "request",
        "monday",
        "anything",
        "letter",
        "sent",
        "consumer",
        "advocacy",
        "virus",
        "statement",
        "afternoon",
        "july",
        "photo",
        "man",
        "headquarters",
        "city",
        "calif",
        "march",
        "specialty",
        "outrage",
        "risberg",
        "existing",
        "ebola",
        "reproduction",
        "promise",
        "lab",
        "niche",
        "industry",
        "tax",
        "research",
        "development",
        "fever",
        "cough",
        "illness",
        "pneumonia",
        "matthew",
        "perrone",
        "twitter",
        "wwwtwittercomap_fdawriter",
        "press",
        "support",
        "howard",
        "education",
        "content"
    ],
    "category": [
        "wires",
        "ap"
    ]
}